ARTICLE | Company News
Isis Pharmaceuticals, GlaxoSmithKline deal
November 24, 2014 8:00 AM UTC
Isis received a $5 million payment from GlaxoSmithKline under an amended 2010 deal to discover and develop up to six therapeutics using Isis’ antisense technology against rare and serious diseases wor...